Torasemide
| Clinical data | |
|---|---|
| Trade names | Demadex, Tortas, Wator | 
| Other names | Torsemide, Torsemide (USAN US) | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a601212 | 
| License data | |
| Routes of administration  | By mouth, intraveneous | 
| Drug class | Loop diuretic | 
| ATC code | |
| Legal status | |
| Legal status | 
  | 
| Pharmacokinetic data | |
| Bioavailability | 80-90% | 
| Protein binding | Highly bound (>99%). | 
| Metabolism | Liver (80%) | 
| Elimination half-life | 3.5 hours; Cirrhosis: 7-8 hours | 
| Identifiers | |
  | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.164.924 | 
| Chemical and physical data | |
| Formula | C16H20N4O3S | 
| Molar mass | 348.42 g·mol−1 | 
| 3D model (JSmol) | |
  | |
  | |
| (what is this?) (verify) | |
Torasemide, also known as torsemide, is a diuretic medication used to treat fluid overload due to heart failure, kidney disease, and liver disease. It is a less preferred treatment for high blood pressure. It is taken by mouth or by injection into a vein.
Common side effects include headache, increased urination, diarrhea, cough, and dizziness. Other side effects may include hearing loss and low blood potassium. Torasemide is a sulfonamide and loop diuretic. Use is not recommended in pregnancy or breastfeeding. It works by decreasing the reabsorption of sodium by the kidneys.
Torasemide was patented in 1974 and came into medical use in 1993. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication. In 2022, it was the 184th most commonly prescribed medication in the United States, with more than 2 million prescriptions.